Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer

Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer

Abstract Background Although gemcitabine has been considered as the first-line drug for advanced pancreatic cancer (PC), development of resistance to gemcitabine severely limits the effectiveness of this chemotherapy, and the underlying mechanism of gemcitabine resistance remains unclear. Various fa...

Full description

Bibliographic Details
Main Authors: Jianyou Gu, Wenjie Huang, Xianxing Wang, Junfeng Zhang, Tian Tao, Yao Zheng, Songsong Liu, Jiali Yang, Zhe-Sheng Chen, Chao-Yun Cai, Jinsui Li, Huaizhi Wang, Yingfang Fan
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Molecular Cancer
Subjects:
Hsa-miR-3178
RhoB
Gemcitabine resistance
PI3K/Akt
Pancreatic cancer
ABC transporters
Online Access:https://doi.org/10.1186/s12943-022-01587-9

Internet

https://doi.org/10.1186/s12943-022-01587-9

Similar Items